Jw Holdings Cash Flow Conversion Efficiency

Latest as of September 2025: 0.118x

Jw Holdings cash flow conversion efficiency. Based on the latest financial reports, Jw Holdings (096760) has a cash flow conversion efficiency ratio of 0.118x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩66.90 Billion ≈ $45.34 Million USD) by net assets (₩567.12 Billion ≈ $384.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jw Holdings (2007–2024)

Cash flow conversion efficiency of Jw Holdings from 2007 to 2024. This chart illustrates how Jw Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jw Holdings share price for real-time trading data and today's change.

Jw Holdings Cash Flow Conversion Ratio Explained

Jw Holdings cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jw Holdings Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Holdings ranked by their cash flow conversion efficiency. Also see 096760 market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
IMC S.A.
F:IM4
0.194x
HIL Limited
NSE:HIL
0.049x
Wismilak Inti Makmur Tbk
JK:WIIM
0.040x
Willy Food
TA:WLFD
0.028x
SPACSphere Acquisition Corp. Class A Ordinary Shares
NASDAQ:SSAC
0.000x
GoldQuest Mining Corp.
V:GQC
-0.067x
GD Express Carrier Bhd
KLSE:0078
0.009x
Nucleus Software Exports Limited
NSE:NUCLEUS
0.137x

Annual Cash Flow Conversion Efficiency for Jw Holdings (2007–2024)

The table below shows the annual cash flow conversion efficiency of Jw Holdings from 2007 to 2024. Review cash generation quality of Jw Holdings to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩521.39 Billion
≈ $353.34 Million
₩97.89 Billion
≈ $66.34 Million
0.188x -41.70%
2023-12-31 ₩348.75 Billion
≈ $236.35 Million
₩112.32 Billion
≈ $76.12 Million
0.322x +2.78%
2022-12-31 ₩333.26 Billion
≈ $225.85 Million
₩104.43 Billion
≈ $70.77 Million
0.313x -12.89%
2021-12-31 ₩304.82 Billion
≈ $206.57 Million
₩109.64 Billion
≈ $74.30 Million
0.360x +10.92%
2020-12-31 ₩334.97 Billion
≈ $227.00 Million
₩108.62 Billion
≈ $73.61 Million
0.324x +15.54%
2019-12-31 ₩351.62 Billion
≈ $238.29 Million
₩98.68 Billion
≈ $66.88 Million
0.281x -42.51%
2018-12-31 ₩401.00 Billion
≈ $271.75 Million
₩195.76 Billion
≈ $132.67 Million
0.488x +1640.33%
2017-12-31 ₩374.73 Billion
≈ $253.95 Million
₩10.51 Billion
≈ $7.12 Million
0.028x +126.65%
2016-12-31 ₩277.59 Billion
≈ $188.12 Million
₩-29.21 Billion
≈ $-19.80 Million
-0.105x -18.65%
2015-12-31 ₩270.31 Billion
≈ $183.18 Million
₩-23.98 Billion
≈ $-16.25 Million
-0.089x -9.45%
2014-12-31 ₩211.94 Billion
≈ $143.63 Million
₩-17.18 Billion
≈ $-11.64 Million
-0.081x +64.60%
2013-12-31 ₩236.03 Billion
≈ $159.95 Million
₩-54.03 Billion
≈ $-36.62 Million
-0.229x -5557.31%
2012-12-31 ₩205.46 Billion
≈ $139.24 Million
₩861.85 Million
≈ $584.07K
0.004x -89.87%
2010-12-31 ₩192.45 Billion
≈ $130.42 Million
₩7.97 Billion
≈ $5.40 Million
0.041x +6.94%
2008-12-31 ₩213.99 Billion
≈ $145.02 Million
₩8.28 Billion
≈ $5.61 Million
0.039x -48.81%
2007-12-31 ₩214.73 Billion
≈ $145.52 Million
₩16.24 Billion
≈ $11.01 Million
0.076x --

About Jw Holdings

KO:096760 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$185.92 Million
₩274.34 Billion KRW
Market Cap Rank
#16617 Global
#613 in Korea
Share Price
₩3965.00
Change (1 day)
-0.88%
52-Week Range
₩3270.00 - ₩4470.00
All Time High
₩26485.64
About

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more